Eagle’s Eye View: What Are the Effects of 1- vs. 3-Month DAPT?

In this week’s View, Dr. Eagle explores the role of one- or three-month DAPT in HBR patients with or without oral anticoagulant therapy after PCI. He then discusses a meta-analysis of the co-administration of mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure. Finally, Dr. Eagle examines the use of PET imaging in following patients with giant cell arteritis. 

 Subscribe to Eagle’s Eye View